LAG3 positivity of TILs was more often seen in TP53 mutated than in not mutated carcinomas (p < 0.001), and it varied across mutation subtypes: A LAG3-positive immune infiltrate was detected in 18%, 42.1% and 66.7% for WT, OT and NT, respectively. Here, LAG3 is linked to carcinoma.